FindTrial
Sign In

thrombolysis therapy

DRUG3 trials

Sponsors

University of Erlangen-Nürnberg Medical School, Leiden University Medical Center, Guri Hagberg

Conditions

Acute Ischemic StrokeAnticoagulant TherapyBleeding in the BrainFactor Xa InhibitorHemorrhagic Transformation Due to Acute StrokeIntracranial HemorrhagesIschemic StrokePulmonary Embolism Acute

Phase 3

Thrombolysis in Factor Xa-inhibitors Trial
RecruitingNCT06878066
Guri HagbergAcute Ischemic Stroke, Anticoagulant Therapy, Bleeding in the Brain +6
Start: 2025-03-14End: 2037-12-31Target: 300Updated: 2026-09-02

Unknown Phase

Stroke Research Consortium in Northern Bavaria (STAMINA)
CompletedNCT04357899
University of Erlangen-Nürnberg Medical SchoolIschemic Stroke
Start: 2006-01-01End: 2020-03-31Updated: 2022-08-02
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
RecruitingNCT06833827
Leiden University Medical CenterPulmonary Embolism Acute
Start: 2025-02-28End: 2029-01-31Target: 111Updated: 2025-02-19

Related Papers

Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.
2025-08-07
IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation
Cerebrovascular Diseases2024-08-23
Endovascular thrombectomy in patients with anterior circulation stroke: an emulated real-world comparison
Neurological Research and Practice2024-07-255 citations